- Report
- March 2025
- 147 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- January 2023
- 125 Pages
Global
From €2367EUR$2,490USD£1,989GBP
- Report
- October 2023
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 70 Pages
Egypt
From €3327EUR$3,500USD£2,795GBP
From €3327EUR$3,500USD£2,795GBP
- Report
- February 2023
- 79 Pages
Saudi Arabia
From €3327EUR$3,500USD£2,795GBP
- Report
- September 2024
- 82 Pages
India
From €3327EUR$3,500USD£2,795GBP
- Report
- February 2023
- 120 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2023
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 112 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4706EUR$4,950USD£3,953GBP
- Report
- January 2023
- 220 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- December 2022
- 122 Pages
North America
From €3280EUR$3,450USD£2,755GBP
- Report
- December 2022
- 137 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- December 2022
- 139 Pages
Asia Pacific
From €3280EUR$3,450USD£2,755GBP
- Report
- September 2022
- 202 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- May 2022
- 347 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- September 2021
- 141 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- September 2020
- 130 Pages
Asia Pacific
From €3280EUR$3,450USD£2,755GBP

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects the airways and makes it difficult to breathe. It is caused by long-term exposure to irritants such as cigarette smoke, air pollution, and chemical fumes. Symptoms of COPD include shortness of breath, wheezing, chest tightness, and coughing. COPD is a major cause of disability and death worldwide.
The COPD market is a rapidly growing segment of the global healthcare industry. It is estimated that COPD affects more than 300 million people worldwide, and the number is expected to increase in the coming years. The market is driven by the increasing prevalence of COPD, the development of new treatments, and the rising demand for better diagnosis and management of the disease.
The COPD market is highly competitive, with many companies offering a range of products and services. Some of the major players in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Merck. These companies are involved in the development of new treatments, diagnostic tools, and other products to improve the quality of life of COPD patients. Show Less Read more